HRZE Fasted/Fed in Newly Diagnosed TB

PHASE2CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

June 30, 2014

Conditions
Tuberculosis
Interventions
DRUG

intravenous administration of 1st line TB drugs, day 1

TB drugs IV on day 1 for calculation of bioavailability while fasting or fed

Trial Locations (1)

Unknown

Sardjito Central Hospital, Yogyakarta

All Listed Sponsors
collaborator

University of Groningen

OTHER

collaborator

Gadjah Mada University

OTHER

lead

University Medical Center Groningen

OTHER

NCT02121314 - HRZE Fasted/Fed in Newly Diagnosed TB | Biotech Hunter | Biotech Hunter